Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 1/20 | 0.70 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.67 |
| ▸ | NT5E | P21589 | 1/20 | 0.65 |
| ▸ | KRAS | P01116 | 3/20 | 0.64 |
| ▸ | RNASEL | Q05823 | 4/20 | 0.61 |
| ▸ | ENPP1 | P22413 | 2/20 | 0.61 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.61 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.61 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.60 |
| ▸ | P2RX3 | P56373 | 2/20 | 0.60 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.60 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.60 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.60 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.60 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.57 |
| ▸ | IMPDH2 | P12268 | 2/20 | 0.56 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21067995 | 1.00 | TGM2 (0.70) | TGM2FUT5NT5EKRASRNASEL | |
| SCHEMBL23176397 | 1.00 | TGM2 (0.70) | TGM2FUT5NT5EKRASRNASEL | |
| SCHEMBL877839 | 1.00 | TGM2 (0.70) | TGM2FUT5NT5EKRASRNASEL | |
| SCHEMBL21256201 | 1.00 | TGM2 (0.70) | TGM2FUT5NT5EKRASRNASEL | |
| SCHEMBL4011876 | 0.99 | TGM2 (0.69) | TGM2FUT5NT5EKRASRNASEL | |
| SCHEMBL1533923 | 0.99 | TGM2 (0.69) | TGM2FUT5NT5EKRASRNASEL | |
| SCHEMBL6512071 | 0.99 | TGM2 (0.69) | TGM2FUT5NT5EKRASRNASEL | |
| SCHEMBL1533928 | 0.99 | TGM2 (0.69) | TGM2FUT5NT5EKRASRNASEL | |
| SCHEMBL25567646 | 0.99 | TGM2 (0.69) | TGM2FUT5NT5EKRASRNASEL | |
| SCHEMBL29355115 | 0.97 | TGM2 (0.65) | TGM2FUT5NT5EKRASRNASEL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 242 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10034903-B2 | Bacterium-based microrobot capable of targeting cancer tissue | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) | 2018-07-31 | — | — | US | claimed |
| US-9339018-B2 | Selective infarcted-tissue-targeting bacteria and use thereof | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERISTY (KR) | 2016-05-17 | — | — | US | claimed |
| US-20150056651-A1 | MICROORGANISM PRODUCTION OF HIGH-VALUE CHEMICAL PRODUCTS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | OPX BIOTECHNOLOGIES INC (US) | 2015-02-26 | — | — | US | claimed |
| US-20140037553-A1 | BACTERIUM-BASED MICROROBOT CAPABLE OF TARGETING CANCER TISSUE | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) | 2014-02-06 | — | — | US | claimed |
| US-20130122541-A1 | MICROORGANISM PRODUCTION OF HIGH-VALUE CHEMICAL PRODUCTS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | THE REGENTS OF THE UNIVERSITY OF COLORADO | 2013-05-16 | — | — | US | claimed |
| EP-1687017-B1 | Methods and compositions for delivering polynucleotides | GENCIA CORP (US) | 2013-03-06 | — | — | EP | claimed |
| EP-2529023-A1 | MICROORGANISM PRODUCTION OF HIGH-VALVE CHEMICAL PRODUCTS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | OPX Biotechnologies Inc. (US) | 2012-12-05 | — | — | EP | claimed |
| US-20120005776-A1 | NONVIRAL VECTORS FOR DELIVERING POLYNUCLEOTIDES TO PLANTS | GENCIA CORPORATION | 2012-01-05 | — | — | US | claimed |
| JP-4838722-B2 | — | — | 2011-12-14 | — | — | JP | claimed |
| WO-2011094457-A1 | MICROORGANISM PRODUCTION OF HIGH-VALVE CHEMICAL PRODUCTS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | OPX BIOTECHNOLOGIES, INC. (US) | 2011-08-04 | — | — | WO | claimed |
| EP-1687017-A4 | METHODS AND COMPOSITIONS FOR DELIVERING POLYNUCLEOTIDES | GENCIA CORP (US) | 2009-08-19 | — | — | EP | claimed |
| WO-2005056752-A9 | METHODS AND COMPOSITIONS FOR DELIVERING POLYNUCLEOTIDES | GENCIA CORP (US) | 2009-07-23 | — | — | WO | claimed |
| US-20080222750-A1 | NONVIRAL VECTORS FOR DELIVERING POLYNUCLEOTIDES TO PLANTS | GENCIA CORPORATION | 2008-09-11 | — | — | US | claimed |
| EP-1644496-A4 | MODIFIED VECTORS FOR ORGANELLE TRANSFECTION | GENCIA CORP (US) | 2006-10-04 | — | — | EP | claimed |
| EP-1687017-A2 | METHODS AND COMPOSITIONS FOR DELIVERING POLYNUCLEOTIDES | Gencia Corporation (US) | 2006-08-09 | — | — | EP | claimed |
| EP-1644496-A2 | MODIFIED VECTORS FOR ORGANELLE TRANSFECTION | Gencia Corporation (US) | 2006-04-12 | — | — | EP | claimed |
| US-20050147993-A1 | Methods and compositions for delivering polynucleotides | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-07-07 | — | — | US | claimed |
| WO-2005056752-A2 | METHODS AND COMPOSITIONS FOR DELIVERING POLYNUCLEOTIDES | GENCIA CORPORATION (US) | 2005-06-23 | — | — | WO | claimed |
| WO-2005001062-A2 | MODIFIED VECTORS FOR ORGANELLE TRANSFECTION | GENCIA CORPORATION (US) | 2005-01-06 | — | — | WO | claimed |
| US-20260128119-A1 | SCREENING METHODS FOR ACINETOBACTER BAUMANNII SPOT ENZYME MODULATORS | Université Libre de Bruxelles (BE) | 2026-05-07 | — | — | US | disclosed |
| US-20260041687-A1 | METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA | PENN STATE RES FOUND (US) | 2026-02-12 | — | — | US | disclosed |
| US-12472185-B2 | Methods for killing antibiotic tolerant bacteria | THE PENN STATE RESEARCH FOUNDATION (US) | 2025-11-18 | — | — | US | disclosed |
| EP-4605090-A1 | SCREENING METHODS FOR ACINETOBACTER BAUMANNII SPOT ENZYME MODULATORS | Université Libre de Bruxelles (BE) | 2025-08-27 | — | — | EP | disclosed |
| WO-2024155027-A1 | ATTENUATED SALMONELLA GALLINARUM EXPRESSING FLIC OR FLIC-HIL2 AND USE THEREOF | 주식회사 오디세우스바이오 | 2024-07-25 | — | — | WO | disclosed |
| US-20240240140-A1 | ATTENUATED SALMONELLA GALLINARUM EXPRESSING FLIC OR FLIC-HIL2 AND USES THEREOF | Odysseus Bio Co., Ltd. (KR) | 2024-07-18 | — | — | US | disclosed |
| US-20240218318-A1 | ATTENUATED SALMONELLA GALLINARUM STRAIN AND USE THEREOF | Odysseus Bio Co., Ltd. (KR) | 2024-07-04 | — | — | US | disclosed |
| WO-2024084070-A1 | SCREENING METHODS FOR ACINETOBACTER BAUMANNII SPOT ENZYME MODULATORS | Université Libre de Bruxelles (BE) | 2024-04-25 | — | — | WO | disclosed |
| US-20240108664-A1 | TUMOR-TARGETING SALMONELLA GALLINARUM STRAIN AND USE THEREOF | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) | 2024-04-04 | — | — | US | disclosed |
| EP-4332228-A1 | ATTENUATED SALMONELLA GALLINARUM STRAIN AND USE THEREOF | Industry Foundation of Chonnam National University (KR) | 2024-03-06 | — | — | EP | disclosed |
| US-11920139-B2 | Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety | THE WASHINGTON UNIVERSITY (US) | 2024-03-05 | — | — | US | disclosed |
| WO-2023172495-A2 | METHODS AND COMPOSITIONS FOR PRODUCTION OF BIOLOGICAL SUBSTANCES IN A GENETICALLY MODIFIED CELL | MAZEF BIOSCIENCES LLC (US) | 2023-09-14 | — | — | WO | disclosed |
| US-20230201206-A1 | METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA | THE PENN STATE RESEARCH FOUNDATION | 2023-06-29 | — | — | US | disclosed |
| US-11654146-B2 | Methods for killing antibiotic tolerant bacteria | THE PENN STATE RESEARCH FOUNDATION (US) | 2023-05-23 | — | — | US | disclosed |
| US-20230128889-A1 | REL/RELA/SPOT SMALL MOLECULES MODULATORS AND SCREENING METHODS | Université Libre de Bruxelles (BE) | 2023-04-27 | — | — | US | disclosed |
| CN-115943211-A | Tumor-targeted salmonella gallinarum strain and application thereof | 全南大学校产学协力团 | 2023-04-07 | — | — | CN | disclosed |
| EP-4158010-A1 | METHODS FOR STABLE GENOMIC INTEGRATION IN RECOMBINANT MICROORGANISMS | BioPlx, Inc. (US) | 2023-04-05 | — | — | EP | disclosed |
| EP-4128250-A1 | REL/RELA/SPOT SMALL MOLECULES MODULATORS AND SCREENING METHODS | Université Libre de Bruxelles (BE) | 2023-02-08 | — | — | EP | disclosed |
| WO-2022231043-A1 | ATTENUATED SALMONELLA GALLINARUM STRAIN AND USE THEREOF | 전남대학교산학협력단 | 2022-11-03 | — | — | WO | disclosed |
| US-20220288135-A1 | LIVE BIOTHERAPEUTIC COMPOSITIONS AND METHODS | BioPlx, Inc. (US) | 2022-09-15 | — | — | US | disclosed |
| EP-4053283-A1 | TUMOR-TARGETING SALMONELLA GALLINARUM STRAIN AND USE THEREOF | Industry Foundation of Chonnam National University (KR) | 2022-09-07 | — | — | EP | disclosed |
| EP-3414332-B1 | IMPROVEMENT OF PHOTOSYNTHETIC ORGANISMS THROUGH THE MODULATION OF GUANOSINE TETRAPHOSPHATE HOMEOSTATIS | CENTRE NAT RECH SCIENT (FR) | 2022-06-29 | — | — | EP | disclosed |
| EP-3996510-A2 | LIVE BIOTHERAPEUTIC COMPOSITIONS AND METHODS | BioPlx, Inc. (US) | 2022-05-18 | — | — | EP | disclosed |
| US-20220025364-A1 | METHODS FOR STABLE GENOMIC INTEGRATION IN RECOMBINANT MICROORGANISMS | COMMENSE BIO, INC. | 2022-01-27 | — | — | US | disclosed |
| US-20210401843-A1 | METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA | THE PENN STATE RESEARCH FOUNDATION | 2021-12-30 | — | — | US | disclosed |
| US-11180765-B2 | Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety | THE ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2021-11-23 | — | — | US | disclosed |
| EP-3064066-B1 | METHOD FOR CHANGING THE DEVELOPMENT PATTERN, INCREASING THE GROWTH AND THE ACCUMULATION OF STARCH, CHANGING THE STRUCTURE OF STARCH AND INCREASING THE RESISTANCE TO WATER STRESS IN PLANTS | TIMAC AGRO ESPANA S A (ES) | 2021-05-19 | — | — | EP | disclosed |
| WO-2021086085-A1 | TUMOR-TARGETING SALMONELLA GALLINARUM STRAIN AND USE THEREOF | (주)최현일바이오랩 | 2021-05-06 | — | — | WO | disclosed |
| US-20210094980-A1 | PRODUCTION METHOD AND PRODUCTION INTERMEDIATE FOR GUANOSINE-3',5'-BISDIPHOSPHATE | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2021-04-01 | — | — | US | disclosed |
| US-20210094980-A1 | PRODUCTION METHOD AND PRODUCTION INTERMEDIATE FOR GUANOSINE-3',5'-BISDIPHOSPHATE | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2021-04-01 | — | — | US | disclosed |
| WO-2021025302-A1 | MAGNETICALLY ACTUATED MICROROBOT USING BIO-BASED ORGANISM | DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2021-02-11 | — | — | WO | disclosed |
| WO-2021007341-A2 | LIVE BIOTHERAPEUTIC COMPOSITIONS AND METHODS | BioPlx, Inc. (US) | 2021-01-14 | — | — | WO | disclosed |
| EP-3750906-A1 | PRODUCTION METHOD AND PRODUCTION INTERMEDIATE FOR GUANOSINE-3',5'-BISDIPHOSPHATE | Tokyo Institute of Technology (JP) | 2020-12-16 | — | — | EP | disclosed |
| EP-3750906-A1 | PRODUCTION METHOD AND PRODUCTION INTERMEDIATE FOR GUANOSINE-3',5'-BISDIPHOSPHATE | Tokyo Institute of Technology (JP) | 2020-12-16 | — | — | EP | disclosed |
| US-20200377897-A1 | REGULATED EXPRESSION OF ANTIGEN AND/OR REGULATED ATTENUATION TO ENHANCE VACCINE IMMUNOGENICITY AND/OR SAFETY | THE WASHINGTON UNIVERSITY | 2020-12-03 | — | — | US | disclosed |
| EP-3720294-A1 | METHOD FOR PRODUCING A PROTEIN PHOSPHOLIPID COMPLEX FROM A CRUSTACEAN CATCH | Rimfrost Technologies AS (NO) | 2020-10-14 | — | — | EP | disclosed |
| US-10774334-B2 | Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety | Arizona Broad of Regents on Behalf of Arizona State University (US) | 2020-09-15 | — | — | US | disclosed |
| US-20200165620-A1 | REGULATED EXPRESSION OF ANTIGEN AND/OR REGULATED ATTENUATION TO ENHANCE VACCINE IMMUNOGENICITY AND/OR SAFETY | THE WASHINGTON UNIVERSITY | 2020-05-28 | — | — | US | disclosed |
| EP-3622080-A1 | IMPROVED METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | Global Bioenergies (FR) | 2020-03-18 | — | — | EP | disclosed |
| WO-2019156240-A1 | PRODUCTION METHOD AND PRODUCTION INTERMEDIATE FOR GUANOSINE-3',5'-BISDIPHOSPHATE | 国立大学法人東京工業大学 | 2019-08-15 | — | — | WO | disclosed |
| WO-2019155639-A1 | PRODUCTION METHOD AND PRODUCTION INTERMEDIATE FOR GUANOSINE-3',5'-BISDIPHOSPHATE | 国立大学法人東京工業大学 | 2019-08-15 | — | — | WO | disclosed |
| WO-2019111055-A1 | METHOD FOR PRODUCING A PROTEIN PHOSPHOLIPID COMPLEX FROM A CRUSTACEAN CATCH | Rimfrost Technologies (NO) | 2019-06-13 | — | — | WO | disclosed |
| US-20190169630-A1 | IMPROVEMENT OF PHOTOSYNTHETIC ORGANISMS THROUGH THE MODULATION OF GUANOSINE TETRAPHOSPHATE HOMEOSTATIS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS ) (FR) | 2019-06-06 | — | — | US | disclosed |
| US-20190119708-A1 | METHOD FOR PRODUCING 3-HYDROXYPROPIONIC ACID AND OTHER PRODUCTS | OPX BIOTECHNOLOGIES, INC. | 2019-04-25 | — | — | US | disclosed |
| WO-2018206262-A9 | IMPROVED METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2019-03-14 | — | — | WO | disclosed |
| EP-3414332-A1 | IMPROVEMENT OF PHOTOSYNTHETIC ORGANISMS THROUGH THE MODULATION OF GUANOSINE TETRAPHOSPHATE HOMEOSTATIS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2018-12-19 | — | — | EP | disclosed |
| WO-2018206262-A1 | IMPROVED METHODS FOR PRODUCING ISOBUTENE FROM 3-METHYLCROTONIC ACID | GLOBAL BIOENERGIES (FR) | 2018-11-15 | — | — | WO | disclosed |
| US-20180320189-A1 | REGULATED EXPRESSION OF ANTIGEN AND/OR REGULATED ATTENUATION TO ENHANCE VACCINE IMMUNOGENICITY AND/OR SAFETY | NATIONAL INSTITUTES OF HEALTH | 2018-11-08 | — | — | US | disclosed |
| US-10100342-B2 | Method for producing 3-hydroxypropionic acid and other products | CARGILL, INCORPORATED (US) | 2018-10-16 | — | — | US | disclosed |
| US-20180246095-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING LYME DISEASE | THE JOHNS HOPKINS UNIVERSITY | 2018-08-30 | — | — | US | disclosed |
| US-10034903-B2 | Bacterium-based microrobot capable of targeting cancer tissue | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) | 2018-07-31 | — | — | US | disclosed |
| EP-2480673-B1 | METHOD FOR PRODUCING 3-HYDROXYPROPIONIC ACID AND OTHER PRODUCTS | OPX BIOTECHNOLOGIES INC (US) | 2018-05-23 | — | — | EP | disclosed |
| US-20180055047-A1 | METHOD FOR CHANGING THE DEVELOPMENT PATTERN, INCREASING THE GROWTH AND THE ACCUMULATION OF STARCH, CHANGING THE STRUCTURE OF STARCH AND INCREASING THE RESISTANCE TO WATER STRESS IN PLANTS | IDEN BIOTECHNOLOGY S. L. (ES) | 2018-03-01 | — | — | US | disclosed |
| US-9902964-B2 | Growth arrested cells useful for producing compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-02-27 | — | — | US | disclosed |
| US-9885051-B2 | Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety | THE ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2018-02-06 | — | — | US | disclosed |
| EP-2814945-B9 | A CELL WITH REDUCED PPGPPASE ACTIVITY | EVONIK DEGUSSA GMBH (DE) | 2017-11-22 | — | — | EP | disclosed |
| EP-2561760-B1 | METHOD FOR INCREASING THE RESISTANCE TO HYDRIC STRESS IN PLANTS | IDEN BIOTECHNOLOGY S L (ES) | 2017-09-06 | — | — | EP | disclosed |
| WO-2017137374-A1 | IMPROVEMENT OF PHOTOSYNTHETIC ORGANISMS THROUGH THE MODULATION OF GUANOSINE TETRAPHOSPHATE HOMEOSTATIS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS - (FR) | 2017-08-17 | — | — | WO | disclosed |
| EP-2814945-B1 | A CELL WITH REDUCED PPGPPASE ACTIVITY | EVONIK DEGUSSA GMBH (DE) | 2017-08-02 | — | — | EP | disclosed |
| US-9673030-B2 | Computer readable storage mediums, methods and systems for normalizing chemical profiles in biological or medical samples detected by mass spectrometry | EMORY UNIVERSITY (US) | 2017-06-06 | — | — | US | disclosed |
| US-9642361-B2 | Method for changing the development pattern, increasing the growth and the accumulation of starch, changing the structure of starch and increasing the resistance to water stress in plants | IDEN BIOTECHNOLOGY, S.L. (ES) | 2017-05-09 | — | — | US | disclosed |
| US-20170114377-A1 | METHOD FOR PRODUCING 3-HYDROXYPROPIONIC ACID AND OTHER PRODUCTS | OPX BIOTECHNOLOGIES, INC. | 2017-04-27 | — | — | US | disclosed |
| US-20170067066-A1 | CELL WITH REDUCED PPGPPASE ACTIVITY | EVONIK DEGUSSA GMBH (DE) | 2017-03-09 | — | — | US | disclosed |
| EP-2844736-B1 | MODIFIED BACTERIA AND USES THEREOF FOR TREATMENT OF CANCER OR TUMOR | UNIV HONG KONG (CN) | 2017-03-01 | — | — | EP | disclosed |
| WO-2017031196-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING LYME DISEASE | THE JOHNS HOPKINS UNIVERSITY (US) | 2017-02-23 | — | — | WO | disclosed |
| WO-2017031216-A1 | COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING LYME DISEASE | THE JOHNS HOPKINS UNIVERSITY (US) | 2017-02-23 | — | — | WO | disclosed |
| EP-3130676-A1 | MUTANT E. COLI STRAIN WITH INCREASED SUCCINIC ACID PRODUCTION | Rice University (US) | 2017-02-15 | — | — | EP | disclosed |
| EP-1781797-B1 | MUTANT E. COLI STRAIN WITH INCREASED SUCCINIC ACID PRODUCTION | RICE UNIVERSITY (US) | 2016-10-19 | — | — | EP | disclosed |
| EP-3064066-A1 | METHOD FOR CHANGING THE DEVELOPMENT PATTERN, INCREASING THE GROWTH AND THE ACCUMULATION OF STARCH, CHANGING THE STRUCTURE OF STARCH AND INCREASING THE RESISTANCE TO WATER STRESS IN PLANTS | Idén Biotechnology, S.L. (ES) | 2016-09-07 | — | — | EP | disclosed |
| US-9428778-B2 | Method for producing 3-hydroxypropionic acid and other products | CARGILL, INCORPORATED (US) | 2016-08-30 | — | — | US | disclosed |
| US-20160199467-A1 | REGULATED EXPRESSION OF ANTIGEN AND/OR REGULATED ATTENTUATION TO ENHANCE VACCINE IMMUNOGENICITY AND/OR SAFETY | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2016-07-14 | — | — | US | disclosed |
| US-9388419-B2 | Methods for producing 3-hydroxypropionic acid and other products | CARGILL, INCORPORATED (US) | 2016-07-12 | — | — | US | disclosed |
| EP-2418281-B1 | Methods and compositions for delivering polynucleotides | GENCIA CORP (US) | 2016-06-01 | — | — | EP | disclosed |
| US-9297015-B2 | Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety | ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2016-03-29 | — | — | US | disclosed |
| US-20150361435-A1 | IDENTIFICATION OF INHIBITORS OF A BACTERIAL STRESS RESPONSE | THE PENN STATE RESEARCH FOUNDATION | 2015-12-17 | — | — | US | disclosed |
| US-20150353939-A1 | Growth Arrested Cells Useful for Producing Compounds | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-12-10 | — | — | US | disclosed |
| US-20150344916-A1 | METHOD FOR PRODUCING 3-HYDROXYPROPIONIC ACID AND OTHER PRODUCTS | OPX BIOTECHNOLOGIES, INC. | 2015-12-03 | — | — | US | disclosed |
| US-9133231-B2 | Compounds for treating bacterial infections | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2015-09-15 | — | — | US | disclosed |
| US-9127284-B2 | Modified bacteria and their uses thereof for the treatment of cancer or tumor | THE UNIVERSITY OF HONG KONG (CN) | 2015-09-08 | — | — | US | disclosed |
| US-20150141325-A1 | IDENTIFICATION OF INHIBITORS OF A BACTERIAL STRESS RESPONSE | THE PENN STATE RESEARCH FOUNDATION | 2015-05-21 | — | — | US | disclosed |
| US-20150072382-A1 | CELL WITH REDUCED PPGPPASE ACTIVITY | EVONIK DEGUSSA GMBH (DE) | 2015-03-12 | — | — | US | disclosed |
| EP-2844736-A1 | MODIFIED BACTERIA AND USES THEREOF FOR TREATMENT OF CANCER OR TUMOR | The University of Hong Kong (CN) | 2015-03-11 | — | — | EP | disclosed |
| US-20150056651-A1 | MICROORGANISM PRODUCTION OF HIGH-VALUE CHEMICAL PRODUCTS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | OPX BIOTECHNOLOGIES INC (US) | 2015-02-26 | — | — | US | disclosed |
| US-8962550-B2 | Identification of inhibitors of a bacterial stress response | THE PENN STATE RESEARCH FOUNDATION (US) | 2015-02-24 | — | — | US | disclosed |
| EP-2814945-A1 | A CELL WITH REDUCED PPGPPASE ACTIVITY | Evonik Industries AG (DE) | 2014-12-24 | — | — | EP | disclosed |
| US-8906390-B2 | Synthetic lipid rafts and methods of use | GENCIA CORPORATION (US) | 2014-12-09 | — | — | US | disclosed |
| US-8883464-B2 | Methods for producing 3-hydroxypropionic acid and other products | OPX BIOTECHNOLOGIES, INC. (US) | 2014-11-11 | — | — | US | disclosed |
| US-20140309186-A1 | Metabolomics-Based Identification of Disease-Causing Agents | GEORGIA TECH RESEARCH CORPORATION | 2014-10-16 | — | — | US | disclosed |
| US-20140234258-A1 | RNA Interferases and Methods of Use Thereof | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2014-08-21 | — | — | US | disclosed |
| US-20140045231-A1 | METHODS FOR PRODUCING 3-HYDROXYPROPIONIC ACID AND OTHER PRODUCTS | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2014-02-13 | — | — | US | disclosed |
| US-20140037553-A1 | BACTERIUM-BASED MICROROBOT CAPABLE OF TARGETING CANCER TISSUE | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) | 2014-02-06 | — | — | US | disclosed |
| WO-2013163893-A1 | MODIFIED BACTERIA AND USES THEREOF FOR TREATMENT OF CANCER OR TUMOR | THE UNIVERSITY OF HONG KONG (CN) | 2013-11-07 | — | — | WO | disclosed |
| US-20130295054-A1 | Modified Bacteria and their Uses thereof for the Treatment of Cancer or Tumor | THE UNIVERSITY OF HONG KONG (CN) | 2013-11-07 | — | — | US | disclosed |
| US-8541550-B2 | Methods and compositions for delivering polynucleotides | GENCIA CORPORATION (US) | 2013-09-24 | — | — | US | disclosed |
| US-20130237435-A1 | GENE CLUSTER, GENE SEARCHING/IDENTIFICATION METHOD, AND APPARATUS FOR THE METHOD | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2013-09-12 | — | — | US | disclosed |
| WO-2013120685-A1 | A CELL WITH REDUCED PPGPPASE ACTIVITY | EVONIK INDUSTRIES AG (DE) | 2013-08-22 | — | — | WO | disclosed |
| US-8507277-B2 | Binding proteins comprising transduction domain operably linked to targeting signal peptide comprising high mobility group boxes; for treatment of mitochondrial diseases | GENCIA CORPORATION (US) | 2013-08-13 | — | — | US | disclosed |
| US-20130203694-A1 | COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | YISSUM RESEARCH DEVELOPMENT CO. OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2013-08-08 | — | — | US | disclosed |
| US-20130171190-A1 | REGULATED EXPRESSION OF ANTIGEN AND/OR REGULATED ATTENTUATION TO ENHANCE VACCINE IMMUNOGENICITY AND/OR SAFETY | THE WASHINGTON UNIVERSITY (US) | 2013-07-04 | — | — | US | disclosed |
| US-8470972-B2 | Nonviral vectors for delivering polynucleotides to plants | GENCIA CORPORATION (US) | 2013-06-25 | — | — | US | disclosed |
| EP-2601205-A2 | GUANINE NUCLEOTIDE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. (IL) | 2013-06-12 | — | — | EP | disclosed |
| US-8445254-B2 | Regulated expression of antigen and/or regulated attentuation to enhance vaccine immunogenicity and/or safety | THE ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2013-05-21 | — | — | US | disclosed |
| US-20130122541-A1 | MICROORGANISM PRODUCTION OF HIGH-VALUE CHEMICAL PRODUCTS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | THE REGENTS OF THE UNIVERSITY OF COLORADO | 2013-05-16 | — | — | US | disclosed |
| US-20130116124-A1 | METHOD FOR CHANGING THE DEVELOPMENT PATTERN, INCREASING THE GROWTH AND THE ACCUMULATION OF STARCH, CHANGING THE STRUCTURE OF STARCH AND INCREASING THE RESISTANCE TO WATER STRESS IN PLANTS | IDEN BIOTECHNOLOGY, S.L. (ES) | 2013-05-09 | — | — | US | disclosed |
| US-20130071893-A1 | METHODS FOR PRODUCING 3-HYDROXYPROPIONIC ACID AND OTHER PRODUCTS | OPX BIOTECHNOLOGIES, INC. (US) | 2013-03-21 | — | — | US | disclosed |
| US-20130071374-A1 | RNA Interferases and Methods of Use Thereof | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2013-03-21 | — | — | US | disclosed |
| EP-1687017-B1 | Methods and compositions for delivering polynucleotides | GENCIA CORP (US) | 2013-03-06 | — | — | EP | disclosed |
| EP-2561760-A2 | METHOD FOR CHANGING THE DEVELOPMENT PATTERN, INCREASING THE GROWTH AND ACCUMULATION OF STARCH, CHANGING THE STRUCTURE OF STARCH AND INCREASING THE RESISTANCE TO HYDRIC STRESS IN PLANTS | Idén Biotechnology, S.L. (ES) | 2013-02-27 | — | — | EP | disclosed |
| US-8372612-B2 | Production of four carbon alcohols using improved strain | BUTAMAX(TM) ADVANCED BIOFUELS LLC (US) | 2013-02-12 | — | — | US | disclosed |
| EP-2529023-A1 | MICROORGANISM PRODUCTION OF HIGH-VALVE CHEMICAL PRODUCTS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | OPX Biotechnologies Inc. (US) | 2012-12-05 | — | — | EP | disclosed |
| US-20120261611-A1 | RARE EARTH REMOVAL OF PHOSPHORUS-CONTAINING MATERIALS | MOLYCORP MINERALS, LLC (US) | 2012-10-18 | — | — | US | disclosed |
| US-20120223022-A1 | CONTAMINANT REMOVAL FROM WATERS USING RARE EARTHS | MOLYCORP MINERALS, LLC (US) | 2012-09-06 | — | — | US | disclosed |
| US-20120187337-A1 | RARE EARTH REMOVAL OF PHOSPHORUS-CONTAINING MATERIALS | MOLYCORP MINERALS, LLC (US) | 2012-07-26 | — | — | US | disclosed |
| US-20120157375-A1 | Identification of Inhibitors of a Bacterial Stress Response | THE PENN STATE RESEARCH FOUNDATION | 2012-06-21 | — | — | US | disclosed |
| WO-2012083226-A1 | IDENTIFICATION OF INHIBITORS OF A BACTERIAL STRESS RESPONSE | THE PENN STATE RESEARCH FOUNDATION (US) | 2012-06-21 | — | — | WO | disclosed |
| US-8183011-B2 | Endoribonuclease; detection of nucleic acid sequence; gene expression; incubation; measurement splitting | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2012-05-22 | — | — | US | disclosed |
| US-20120103909-A1 | PARTICULATE CERIUM DIOXIDE AND AN IN SITU METHOD FOR MAKING AND USING THE SAME | MOLYCORP MINERALS, LLC (US) | 2012-05-03 | — | — | US | disclosed |
| WO-2012039484-A1 | GENE CLUSTER, GENE SEARCHING/IDENTIFICATION METHOD, AND APPARATUS FOR THE METHOD | 独立行政法人産業技術総合研究所 (JP) | 2012-03-29 | — | — | WO | disclosed |
| US-20120074071-A1 | PROCESS FOR TREATING WATERS AND WATER HANDLING SYSTEMS TO REMOVE SCALES AND REDUCE THE SCALING TENDENCY | MOLYCORP MINERALS, LLC (US) | 2012-03-29 | — | — | US | disclosed |
| US-8119385-B2 | Nucleic acids and proteins and methods for making and using them | BP CORPORATION NORTH AMERICA INC. (US) | 2012-02-21 | — | — | US | disclosed |
| EP-2418281-A2 | Methods and compositions for delivering polynucleotides | Gencia Corporation (US) | 2012-02-15 | — | — | EP | disclosed |
| WO-2012017434-A2 | COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2012-02-09 | — | — | WO | disclosed |
| US-20120005776-A1 | NONVIRAL VECTORS FOR DELIVERING POLYNUCLEOTIDES TO PLANTS | GENCIA CORPORATION | 2012-01-05 | — | — | US | disclosed |
| US-20110300600-A1 | METHODS AND COMPOSITIONS FOR DELIVERING POLYNUCLEOTIDES | GENCIA CORPORATION | 2011-12-08 | — | — | US | disclosed |
| US-20110296543-A1 | NUCLEIC ACIDS AND PROTEINS AND METHODS FOR MAKING AND USING THEM | THE UNIVERSITY OF CALIFORNIA (US) | 2011-12-01 | — | — | US | disclosed |
| US-8062891-B2 | Binding proteins comprising transduction domain operably linked to targeting signal peptide comprising high mobility group boxes | GENCIA CORPORATION (US) | 2011-11-22 | — | — | US | disclosed |
| US-20110282587-A1 | COMPUTER READABLE STORAGE MEDIUMS, METHODS AND SYSTEMS FOR NORMALIZING CHEMICAL PROFILES IN BIOLOGICAL OR MEDICAL SAMPLES DETECTED BY MASS SPECTROMETRY | EMORY UNIVERSITY (US) | 2011-11-17 | — | — | US | disclosed |
| US-8039587-B2 | Recombinant high mobility polypeptide comprisingprotein transduction domain linked to non-nuclear organelle targeting signal; gene transfer vector | GENCIA CORPORATION (US) | 2011-10-18 | — | — | US | disclosed |
| US-20110246081-A1 | Metabolomics-Based Identification of Disease-Causing Agents | GEORGIA TECH RESEARCH CORPORATION (US) | 2011-10-06 | — | — | US | disclosed |
| WO-2011094457-A1 | MICROORGANISM PRODUCTION OF HIGH-VALVE CHEMICAL PRODUCTS, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | OPX BIOTECHNOLOGIES, INC. (US) | 2011-08-04 | — | — | WO | disclosed |
| US-20110086813-A1 | COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2011-04-14 | — | — | US | disclosed |
| EP-2302040-A1 | Medical use of mRNA interferase | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2011-03-30 | — | — | EP | disclosed |
| WO-2011034397-A2 | METHOD FOR PREDICTING DRUG TARGETS AND SCREENING FOR DRUGS FOR PATHOGENIC MICROORGANISMS USING ESSENTIAL METABOLITES | 한국과학기술원 (KR) | 2011-03-24 | — | — | WO | disclosed |
| EP-2298869-A1 | Recombinant protein production in the presence of mRNA interferase | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2011-03-23 | — | — | EP | disclosed |
| US-7855060-B2 | Method for producing an L-amino acid using a bacterium of the Enterobacteriaceae family by inactivating a gene encoding a toxin of a bacterial toxin-antitoxin pair | AJINOMOTO CO., INC. (JP) | 2010-12-21 | — | — | US | disclosed |
| EP-1434800-B1 | IMMUNOGLOBULIN HAVING PARTICULAR FRAMEWORK SCAFFOLD AND METHODS OF MAKING AND USING | FRAUNHOFER GES FORSCHUNG (DE) | 2010-12-01 | — | — | EP | disclosed |
| EP-2230312-A1 | Probe compound for detecting and isolating enzymes and means and methods using the same | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2010-09-22 | — | — | EP | disclosed |
| US-20100234287-A1 | Targeting Bacterial Suicide Pathways for the Development of Novel Antibiotics | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2010-09-16 | — | — | US | disclosed |
| US-7790416-B2 | Mutant E. coli strain with increased succinic acid production | RICE UNIVERSITY (US) | 2010-09-07 | — | — | US | disclosed |
| US-7723097-B2 | Escherichia coli strains that over-produce L-threonine and processes for their production | ARCHER-DANIELS-MIDLAND COMPANY (US) | 2010-05-25 | — | — | US | disclosed |
| US-20100124558-A1 | REGULATED EXPRESSION OF ANTIGEN AND/OR REGULATED ATTENTUATION TO ENHANCE VACCINE IMMUNOGENICITY AND/OR SAFETY | THE ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2010-05-20 | — | — | US | disclosed |
| EP-1856243-B1 | PROCESS FOR PRODUCING AN L-AMINO ACID EMPLOYING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY WITH ATTENUATED LEUO EXPRESSION | AJINOMOTO KK (JP) | 2010-04-21 | — | — | EP | disclosed |
| EP-2150616-A2 | REGULATED SYNTHESIS OF ANTIGEN AND/OR REGULATED ATTENTUATION TO ENHANCE VACCINE IMMUNOGENICS AND/OR SAFETY | Arizona Board of Regents, acting for and on behalf of Arizona State University (US) | 2010-02-10 | — | — | EP | disclosed |
| EP-1678301-B1 | INDUCIBLE BACTERIAL EXPRESSION SYSTEM UTILISING SSPA PROMOTER FROM SALMONELLA | UNIV QUEENSLAND (AU) | 2009-12-09 | — | — | EP | disclosed |
| WO-2009116044-A2 | COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2009-09-24 | — | — | WO | disclosed |
| EP-1463836-B1 | VECTOR MEDIATED ORGANELLE TRANSFECTION | UNIV VIRGINIA (US) | 2009-09-16 | — | — | EP | disclosed |
| US-20090215129-A1 | Method for Producing an L-Amino Acid Using a Bacterium of the Enterobacteriaceae Family Having Expression of the leuO Gene Attenuated | AJINOMOTO CO., INC. (JP) | 2009-08-27 | — | — | US | disclosed |
| US-20090203139-A1 | PRODUCTION OF FOUR CARBON ALCOHOLS USING IMPROVED STRAIN | E.I. DU PONT DE NEMOURS AND COMPANY | 2009-08-13 | — | — | US | disclosed |
| EP-1848811-B1 | A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY | AJINOMOTO KK (JP) | 2009-08-05 | — | — | EP | disclosed |
| US-20090186358-A1 | Pathway Analysis of Cell Culture Phenotypes and Uses Thereof | WYETH (US) | 2009-07-23 | — | — | US | disclosed |
| WO-2009082681-A1 | PRODUCTION OF FOUR CARBON ALCOHOLS USING IMPROVED STRAIN | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2009-07-02 | — | — | WO | disclosed |
| US-20090124012-A1 | TOXIN/ANTITOXIN SYSTEMS AND METHODS FOR REGULATING CELLULAR GROWTH, METABOLIC ENGINEERING AND PRODUCTION OF RECOMBINANT PROTEINS | MAZEF BIOSCIENCES, LLC (US) | 2009-05-14 | — | — | US | disclosed |
| WO-2009052186-A1 | METABOLOMICS-BASED IDENTIFICATION OF DISEASE-CAUSING AGENTS | GEORGIA TECH RESEARCH CORPORATION (US) | 2009-04-23 | — | — | WO | disclosed |
| WO-2009025888-A2 | REGULATED SYNTHESIS OF ANTIGEN AND/OR REGULATED ATTENTUATION TO ENHANCE VACCINE IMMUNOGENICS AND/OR SAFETY | THE ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2009-02-26 | — | — | WO | disclosed |
| EP-1999280-A2 | TARGETING BACTERIAL SUICIDE PATHWAYS FOR THE DEVELOPMENT OF NOVEL ANTIBIOTICS | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2008-12-10 | — | — | EP | disclosed |
| US-20080222750-A1 | NONVIRAL VECTORS FOR DELIVERING POLYNUCLEOTIDES TO PLANTS | GENCIA CORPORATION | 2008-09-11 | — | — | US | disclosed |
| US-20080113416-A1 | Method for Producing an L-Amino Acid Using a Bacterium of the Enterobacteriaceae Family | AJINOMOTO CO., INC. (JP) | 2008-05-15 | — | — | US | disclosed |
| US-20080058275-A1 | Rna Interferases And Methods Of Use Thereof | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2008-03-06 | — | — | US | disclosed |
| EP-1678301-A4 | INDUCIBLE BACTERIAL EXPRESSION SYSTEM UTILISING SSPA PROMOTER FROM SALMONELLA | UNIV QUEENSLAND (AU) | 2008-03-05 | — | — | EP | disclosed |
| US-20070275011-A1 | Inducible Bacterial Expression System Utilising Sspa Promoter from Salmonella | THE UNIVERSITY OF QUEENSLAND (AU) | 2007-11-29 | — | — | US | disclosed |
| US-20070275924-A1 | Synthetic Lipid Rafts and Methods of Use | GENCIA CORPORATION | 2007-11-29 | — | — | US | disclosed |
| EP-1856243-A2 | METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY WITH ATTENUATED LEUO EXPRESSION | Ajinomoto Co., Inc. (JP) | 2007-11-21 | — | — | EP | disclosed |
| EP-1848811-A1 | A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY | Ajinomoto Co., Inc. (JP) | 2007-10-31 | — | — | EP | disclosed |
| WO-2007109781-A2 | TARGETING BACTERIAL SUICIDE PATHWAYS FOR THE DEVELOPMENT OF NOVEL ANTIBIOTICS | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2007-09-27 | — | — | WO | disclosed |
| US-7262046-B2 | Aerobic succinate production in bacteria | RICE UNIVERSITY (US) | 2007-08-28 | — | — | US | disclosed |
| US-20070196334-A1 | Modified vectors for organelle transfection | Khan, Shaharyar | 2007-08-23 | — | — | US | disclosed |
| US-20070184539-A1 | Mutant E. coli Strain with Increased Succinic Acid Production | RICE UNIVERSITY (US) | 2007-08-09 | — | — | US | disclosed |
| EP-1639086-A4 | RNA INTERFERASES AND METHODS OF USE THEREOF | UNIV NEW JERSEY MED (US) | 2007-07-11 | — | — | EP | disclosed |
| EP-1801117-A1 | Means and methods for regulating amino acid pools and/or transport | Friesland Brands B.V. (NL) | 2007-06-27 | — | — | EP | disclosed |
| EP-1789569-A2 | HIGH SUCCINATE PRODUCING BACTERIA | Rice University (US) | 2007-05-30 | — | — | EP | disclosed |
| US-7223567-B2 | Mutant E. coli strain with increased succinic acid production | RICE UNIVERSITY (US) | 2007-05-29 | — | — | US | disclosed |
| EP-1781797-A2 | MUTANT E. COLI STRAIN WITH INCREASED SUCCINIC ACID PRODUCTION | Rice University (US) | 2007-05-09 | — | — | EP | disclosed |
| US-20070087378-A1 | Polynucleotide and polypeptide fat metabolism regulators and uses thereof | THE GENERAL HOSPITAL CORPORATION (US) | 2007-04-19 | — | — | US | disclosed |
| US-20070042030-A1 | Preparation for the application of agents in mini-droplets | IDEA AG (DE) | 2007-02-22 | — | — | US | disclosed |
| US-7175999-B2 | Identifying nucleotide sequences which code fat metabolism regulator protein (lpo-4)s for preventing and treating obesity and eating disorders | THE GENERAL HOSPITAL CORPORATION (US) | 2007-02-13 | — | — | US | disclosed |
| US-20060252090-A1 | Nanomachine compositions and methods of use | EVANS GLEN A | 2006-11-09 | — | — | US | disclosed |
| WO-2006103936-A2 | METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY WITH ATTENUATED LEUO EXPRESSION | AJINOMOTO CO., INC. (JP) | 2006-10-05 | — | — | WO | disclosed |
| US-20060211647-A1 | Nonviral vectors for delivering polynucleotides | GENCIA CORPORATION (US) | 2006-09-21 | — | — | US | disclosed |
| US-20060205044-A1 | Escherichia coli strains that over-produce L-threonine and processes for their production | ARCHER-DANIELS-MIDLAND COMPANY | 2006-09-14 | — | — | US | disclosed |
| WO-2006088235-A1 | A METHOD FOR PRODUCING AN L-AMINO ACID USING A BACTERIUM OF THE ENTEROBACTERIACEAE FAMILY | AJINOMOTO CO., INC. (JP) | 2006-08-24 | — | — | WO | disclosed |
| EP-1678301-A1 | INDUCIBLE BACTERIAL EXPRESSION SYSTEM UTILISING SSPA PROMOTER FROM SALMONELLA | The University of Queensland (AU) | 2006-07-12 | — | — | EP | disclosed |
| EP-1434800-A4 | IMMUNOGLOBULIN HAVING PARTICULAR FRAMEWORK SCAFFOLD AND METHODS OF MAKING AND USING | FRAUNHOFER GES FORSCHUNG (DE) | 2006-05-10 | — | — | EP | disclosed |
| US-20060078907-A1 | Nanomachine compositions and methods of use | EVANS GLEN A | 2006-04-13 | — | — | US | disclosed |
| WO-2006034156-A2 | HIGH SUCCINATE PRODUCING BACTERIA | RICE UNIVERSITY (US) | 2006-03-30 | — | — | WO | disclosed |
| EP-1639086-A2 | RNA INTERFERASES AND METHODS OF USE THEREOF | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2006-03-29 | — | — | EP | disclosed |
| WO-2006031424-A2 | MUTANT E. COLI STRAIN WITH INCREASED SUCCINIC ACID PRODUCTION | RICE UNIVERSITY (US) | 2006-03-23 | — | — | WO | disclosed |
| US-20060046288-A1 | Mutant E. coli strain with increased succinic acid production | NATIONAL SCIENCE FOUNDATION | 2006-03-02 | — | — | US | disclosed |
| WO-2006020663-A2 | AEROBIC SUCCINATE PRODUCTION IN BACTERIA | RICE UNIVERSITY (US) | 2006-02-23 | — | — | WO | disclosed |
| US-20060040368-A1 | Aerobic succinate production in bacteria | NATIONAL SCIENCE FOUNDATION | 2006-02-23 | — | — | US | disclosed |
| US-20060008546-A1 | Organisms with enhanced histidine biosynthesis and their use in animal feeds | CARGILL, INCORPORATED | 2006-01-12 | — | — | US | disclosed |
| US-20050147993-A1 | Methods and compositions for delivering polynucleotides | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-07-07 | — | — | US | disclosed |
| US-20050106688-A1 | Method for producing L-amino acid | AJINOMOTO CO., INC. (JP) | 2005-05-19 | — | — | US | disclosed |
| WO-2005024019-A1 | INDUCIBLE BACTERIAL EXPRESSION SYSTEM UTILISING SSPA PROMOTER FROM SALMONELLA | THE UNIVERSITY OF QUEENSLAND (AU) | 2005-03-17 | — | — | WO | disclosed |
| US-20050037420-A1 | Immunoglobulin having particular framework scaffold and methods of making and using | ZHANG MEI-YUN (US) | 2005-02-17 | — | — | US | disclosed |
| WO-2004113498-A2 | RNA INTERFERASES AND METHODS OF USE THEREOF | UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY (US) | 2004-12-29 | — | — | WO | disclosed |
| EP-1486570-A1 | Method for producing L-amino acid | Ajinomoto Co., Inc. (JP) | 2004-12-15 | — | — | EP | disclosed |
| US-20040171517-A1 | Compounds and methods for modulating bacterial functions | UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE ENTRE AT FORT WORTH | 2004-09-02 | — | — | US | disclosed |
| WO-2004056996-A2 | THE ESCHERICHIA COLI CSRC GENE AND USES THEREOF FOR BIOFILM MODULATION | UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER AT FORT WORTH (US) | 2004-07-08 | — | — | WO | disclosed |
| EP-1434800-A2 | IMMUNOGLOBULIN HAVING PARTICULAR FRAMEWORK SCAFFOLD AND METHODS OF MAKING AND USING | FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2004-07-07 | — | — | EP | disclosed |
| US-20040009927-A1 | Methods and compounds for reducing biofilm formulation | UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTRE AT FORT WORTH | 2004-01-15 | — | — | US | disclosed |
| US-20030190601-A1 | Useful for diagnosis and therapy, research tools for drug discovery | MPEX BIOSCIENCES, INC. | 2003-10-09 | — | — | US | disclosed |
| US-6630583-B1 | Isolated nucleic acid encoding a peptide of given amino acid sequence; pneumococcus | ST. JUDE CHILDREN'S RESEARCH HOSPITAL | 2003-10-07 | — | — | US | disclosed |
| WO-2003025124-A2 | IMMUNOGLOBULIN HAVING PARTICULAR FRAMEWORK SCAFFOLD AND METHODS OF MAKING AND USING | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2003-03-27 | — | — | WO | disclosed |
| US-20020076722-A1 | Antibiotic hypersusceptibility mutations in bacteria | INFLUX, INC. | 2002-06-20 | — | — | US | disclosed |
| EP-1188829-A2 | Antibiotic hypersusceptibility mutations in bacteria | The Board of Trustees of the University of illinois (US) | 2002-03-20 | — | — | EP | disclosed |
| EP-0673439-B2 | Method for detecting environmental insults | DU PONT (US) | 2001-07-04 | — | — | EP | disclosed |
| WO-2001010413-A2 | PERIODIC STRUCTURES COMPRISING LIPIDS, POLYELECTROLYTES, AND STRUCTURES-INDUCING SOLUBLE OLIGOVALENT LINKERS | IDEA AG (DE) | 2001-02-15 | — | — | WO | disclosed |
| US-6165500-A | Preparation for the application of agents in mini-droplets | IDEA AG (DE) | 2000-12-26 | — | — | US | disclosed |
| US-5998159-A | MEASURING ACCUMULATION OF BACTERIA | RIBOGENE, INC. (US) | 1999-12-07 | — | — | US | disclosed |
| US-5989864-A | STAPHYLOCOCCUS BACTERICIDES AND BACTERIOSTATS | SMITHKLINE BEECHAM CORPORATION (US) | 1999-11-23 | — | — | US | disclosed |
| WO-1999057281-A2 | PEPTIDE ANTIBIOTICS WHICH INHIBIT THE GROWTH OF PNEUMOCOCCI, ABC TRANSPORTER AND TWO-COMPONENT SIGNAL TRANSDUCTION SYSTEM PROTEINS FROM STREPTOCOCCUS PNEUMONIAE, AND METHODS USING THE SAME | ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) | 1999-11-11 | — | — | WO | disclosed |
| EP-0943000-A1 | A SMALL VOLUME, HIGHLY SENSITIVE METHOD FOR DETECTING ENVIRONMENTAL INSULTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-09-22 | — | — | EP | disclosed |
| WO-1999040912-A1 | METHOD OF STIMULATING APOPTOSIS USING TRICHOTHECENE MYCOTOXINS | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) | 1999-08-19 | — | — | WO | disclosed |
| WO-1998021347-A1 | A SMALL VOLUME, HIGHLY SENSITIVE METHOD FOR DETECTING ENVIRONMENTAL INSULTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1998-05-22 | — | — | WO | disclosed |
| EP-0839910-A2 | Spo-rel, a Staphylococcus relA/spot homologue | SMITHKLINE BEECHAM CORPORATION (US) | 1998-05-06 | — | — | EP | disclosed |
| US-5683868-A | GENETICALLY ENGINEERED E. COLI, BIOLUMINESCENCE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1997-11-04 | — | — | US | disclosed |
| EP-0673439-B1 | Method for detecting environmental insults | DU PONT (US) | 1997-04-23 | — | — | EP | disclosed |
| WO-1995003695-A1 | NOVEL FUNGICIDAL PROPERTIES OF METABOLITES, CULTURE BROTH, STILBENE DERIVATIVES AND INDOLE DERIVATIVES PRODUCED BY THE BACTERIA XENORHABDUS AND PHOTORHABDUS SPP. | AGRO-BIOTECH CORPORATION (US) | 1995-02-09 | — | — | WO | disclosed |
| US-4661443-A | FORMATION OF INITIAL NH2-TERMINAL DIPEPTIDES AND TRIPEPTIDES | HOFFMANN-LA ROCHE INC. (US) | 1987-04-28 | — | — | US | disclosed |
| US-4152209-A | CULTIVATING A STRAIN OF STREPTOMYCES OR STREPTOVERTICILLIUM | SANRAKU-OCEAN CO., LTD. (JP) | 1979-05-01 | — | — | US | disclosed |
| US-4141972-A | Purine nucleoside 5'-phosphate (mono, di or tri) 3'(2')-diphosphates and processes for their preparation | SANRAKU-OCEAN CO., LTD. (JP) | 1979-02-27 | — | — | US | disclosed |
| US-4059487-A | Purine nucleoside 5'-phosphate (mono, di or tri) 3'(2')-diphosphates and processes for their preparation | SANRAKU-OCEAN CO., LTD. (JA) | 1977-11-22 | — | — | US | disclosed |
| US-3883508-A | Process for the preparation of guanosine tetra- and penta-phosphates and products | HOFFMANN LA ROCHE | 1975-05-13 | — | — | US | disclosed |
| US-3883508-A | Process for the preparation of guanosine tetra- and penta-phosphates and products | HOFFMANN LA ROCHE | 1975-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210094980-A1 | PRODUCTION METHOD AND PRODUCTION INTERMEDIATE FOR GUANOSINE-3',5'-BISDIPHOSPHATE | ITPA, GMPS, GDA | TGM2 336/4885FUT5 1237/4885NT5E 151/4885 |
| US-20120005776-A1 | NONVIRAL VECTORS FOR DELIVERING POLYNUCLEOTIDES TO PLANTS | PHAX, SARS1, MAVS | TGM2 2966/4885FUT5 4108/4885NT5E 1561/4885 |
| US-20100234287-A1 | Targeting Bacterial Suicide Pathways for the Development of Novel Antibiotics | ANTXR2, CLPX, PRDX5 | TGM2 3538/4885FUT5 3036/4885NT5E 577/4885 |
| US-20260041687-A1 | METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA | VDAC1, VDAC3, VIL1 | TGM2 2609/4885FUT5 1534/4885NT5E 488/4885 |
| US-11654146-B2 | Methods for killing antibiotic tolerant bacteria | CLPP, SPOUT1, CASP3 | TGM2 1686/4885FUT5 986/4885NT5E 387/4885 |
| US-20050037420-A1 | Immunoglobulin having particular framework scaffold and methods of making and using | IGLV6-57, IGSF11, VSIR | TGM2 862/4885FUT5 2421/4885NT5E 2811/4885 |
| US-20260128119-A1 | SCREENING METHODS FOR ACINETOBACTER BAUMANNII SPOT ENZYME MODULATORS | STUB1, PPME1, BPGM | TGM2 938/4885FUT5 3825/4885NT5E 2350/4885 |
| US-20110086813-A1 | COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | REL, RELA, NFKB1 | TGM2 1523/4885FUT5 1680/4885NT5E 492/4885 |
| US-20130203694-A1 | COMPOUNDS FOR TREATING BACTERIAL INFECTIONS | REL, RELA, RRP1B | TGM2 2693/4885FUT5 3488/4885NT5E 4221/4885 |
| US-20210401843-A1 | METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA | CLPP, SPOUT1, CASP3 | TGM2 1686/4885FUT5 986/4885NT5E 387/4885 |
| US-12472185-B2 | Methods for killing antibiotic tolerant bacteria | CLPP, SPOUT1, CASP3 | TGM2 1686/4885FUT5 986/4885NT5E 387/4885 |
| US-20230201206-A1 | METHODS FOR KILLING ANTIBIOTIC TOLERANT BACTERIA | CLPP, SPOUT1, CASP3 | TGM2 1686/4885FUT5 986/4885NT5E 387/4885 |
| US-20070042030-A1 | Preparation for the application of agents in mini-droplets | FABP4, NPC1L1, LIPA | TGM2 3115/4885FUT5 2349/4885NT5E 3436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.